Home
About us
Industries
Services
Technologies
Clients
Help

Tactiq collaboration wins grant for ground breaking cancer imaging technology
Tactiq has a key role in a new UK collaboration which has been awarded a £325k grant from the UK’s Technology Strategy Board, to support the development of a groundbreaking Optical Coherence Tomography (OCT) imaging technology that hopes to revolutionise cancer diagnosis and treatment.

The collaboration is between Tactiq, optical imaging company Michelson Diagnostics, University of Cardiff, Gloucestershire Hospitals NHS Foundation Trust, National Physical Laboratory and semiconductor specialist Kamelian. Download the full press release Tactiq_OCT [66KB]

Optical Coherence Tomography

Glaucoma Screening device launched
Tactiq has been supporting start up company Applied Neurodiagnostics developing a ground-breaking pupil measuring device which has just launched. The Pupilmetrix PLR60 uses advanced tracking and measuring technology to record the patient's pupil movement and sophisticated software to assess the patient's risk of glaucoma. Tactiq has played a major role in the development of the electronics, software and user interface to produce a high quality, high performance innovative product. .

PLR60

Tactiq exhibit at this year's Medical Innovation Show
Come and join Tactiq at this premier event for healthcare innovators. On 25th June at the London Olympia centre many of the UK's leading medical companies and technology users join to discuss major advancements in medical technology. Tactiq's engineers will be on hand to discuss your ideas in confidence and give technical guidance if required. .